Clinical Comparison of Biliary Iodine-125 Stent and Bare Metal Stent in Treatment of Bismuth Corlette III Cholangiocarcinoma Complicated with Obstructive Jaundice

Fei SONG; Yingying XIANG; Jiayin CHE; Hongyang LI; Wenyong XU; Lingxiao WEI; Ming HUANG

doi:10.12259/j.issn.2095-610X.S20221110

Volume 43 Issue 11

Nov. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(11): 85-89

Fei SONG, Yingying XIANG, Jiayin CHE, Hongyang LI, Wenyong XU, Lingxiao WEI, Ming HUANG. Clinical Comparison of Biliary Iodine-125 Stent and Bare Metal Stent in Treatment of Bismuth Corlette III Cholangiocarcinoma Complicated with Obstructive Jaundice[J]. Journal of Kunming Medical University, 2022, 43(11): 85-89. doi: 10.12259/j.issn.2095-610X.S20221110

Citation:

Fei SONG, Yingying XIANG, Jiayin CHE, Hongyang LI, Wenyong XU, Lingxiao WEI, Ming HUANG. Clinical Comparison of Biliary Iodine-125 Stent and Bare Metal Stent in Treatment of Bismuth Corlette III Cholangiocarcinoma Complicated with Obstructive Jaundice[J]. Journal of Kunming Medical University, 2022, 43(11): 85-89. doi: 10.12259/j.issn.2095-610X.S20221110

Citation:

Fei SONG, Yingying XIANG, Jiayin CHE, Hongyang LI, Wenyong XU, Lingxiao WEI, Ming HUANG. Clinical Comparison of Biliary Iodine-125 Stent and Bare Metal Stent in Treatment of Bismuth Corlette III Cholangiocarcinoma Complicated with Obstructive Jaundice[J]. Journal of Kunming Medical University, 2022, 43(11): 85-89. doi: 10.12259/j.issn.2095-610X.S20221110

PDF( 863 KB)

Clinical Comparison of Biliary Iodine-125 Stent and Bare Metal Stent in Treatment of Bismuth Corlette III Cholangiocarcinoma Complicated with Obstructive Jaundice

doi: 10.12259/j.issn.2095-610X.S20221110

1.
Dept. of Invasive Intervention，The 3rd Affiliated Hospital of Kunming Medical University/ Yunnan Cancer Hospital，Kunming Yunnan 650118
2.
Dept. of Stomatology，Yan’an Hospital，Kunming Yunnan 650051
3.
Dept. of Hepatobiliary and Pancreatic Surgery， The 3rd Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital，Kunming Yunnan 650118，China

Received Date: 2022-04-16
Publish Date: 2022-11-25

Abstract

Abstract

Objective To compare the efficacy of biliary ¹²⁵I seed stent and bare metal stent in the treatment of Bismuth Corlette Ⅲ cholangiocarcinoma complicated with obstructive jaundice. Methods A total of 51 patients with malignant biliary obstruction caused by Bismuth Corlette Ⅲ cholangiocarcinoma who were treated in our department from January 2010 to June 2018 were systematically retrospectively collected, of whom 25 were in the ¹²⁵I seed stent implantation group （observation group）. There were 26 cases in the bare metal stent implantation group （control group）, and the preoperative and postoperative liver function, complication rate, stent patency time and survival time were compared between the two groups. Results The liver function and jaundice degree of patients in the ¹²⁵I seed stent implantation group （observation group） and bare metal stent implantation group （control group） were significantly improved at 1 month after surgery. Compared with the control group, the observation group did not increase the incidence of postoperative complications. The average stent patency time in the observation group was （369.20±231.64） d, and the stent patency time was 310.05 d in the control group, the average stent patency time in the control group was （194.57±118.09） d, and the median stent patency time was 142.52 d. The stent patency time in the observation group was significantly longer than that in the control group （P＜0.05）. The median survival period was （334.24 ± 193.38） d, and the median survival period was 385.21 d. The average survival period of the control group was （251.23 ± 182.51） d, and the median survival period was 274.43 d. The survival period of patients in the observation group was significantly longer than that in the control group （P＜0.05）. Conclusion Compared with bare metal stent, biliary ¹²⁵I seed stent can significantly reduce stent restenosis rate, prolong stent patency time, and improve patient survival without increasing postoperative complications.
- Cholangiocarcinoma,
- ¹²⁵I seed stent,
- Bare metal stent,
- Malignant obstructive jaundice

FullText(HTML)

References(15)

References

[1]	Benavides M,Antón A,Gallego J M A,et al. Biliary tract cancers:SEOM clinical guidelines[J]. Clinical & Translational Oncology,2015,17(12):982-987.
[2]	鲍萍萍,吴春晓,张敏璐,等. 2015年上海市恶性肿瘤流行特征分析[J]. 中国癌症杂志,2019,29(2):81-99. doi: 10.19401/j.cnki.1007-3639.2019.02.001
[3]	庄志泉,马婧嶔,罗剑钧,等. 碘-125粒子条联合胆道金属支架植入治疗恶性梗阻性黄疸的长期疗效及预后因素分析[J]. 复旦学报(医学版),2021,48(3):300-306. doi: 10.3969/j.issn.1672-8467.2021.03.003
[4]	Ljungdahl M,Osterberg J,Ransjö U,et al. Inflammatory response in patients with malignant obstructive jaundice.[J]. Scand J Gastroenterol,2007,42(1):94-102. doi: 10.1080/00365520600825190
[5]	Sha J,Dong Y,Niu H. A prospective study of risk factors for in-hospital mortality in patients with malignant obstructive jaundice undergoing percutaneous biliary drainage[J]. Medicine (Baltimore),2019,98(15):e15131.
[6]	陈伟伟,黄坤,刘锐,等. 经皮肝穿刺胆管引流术联合胆道支架植入术治疗高位恶性梗阻性黄疸的效果及预后影响因素分析[J]. 临床肝胆病杂志,2019,35(3):559-564. doi: 10.3969/j.issn.1001-5256.2019.03.021
[7]	罗详冲,李高峰. PD-1 抑制剂卡瑞利珠单抗在晚期恶性肿瘤中的应用进展[J]. 解放军医学杂志,2020,45(6):672-679. doi: 10.11855/j.issn.0577-7402.2020.06.16
[8]	万巍,许晨,杨魏,等. 高位恶性梗阻性黄疸介入治疗预后因素分析[J]. 介入放射学杂志,2020,29(5):479-482. doi: 10.3969/j.issn.1008-794X.2020.05.013
[9]	Kim H S,Lee D K,Kim H G,et al. Features of malignant biliary obstruction affecting the patency of metallic stents:A multicenter study[J]. Gastrointest Endosc,2002,55(3):359-365. doi: 10.1067/mge.2002.121603
[10]	陶为杰,石小举,王广义. ¹²⁵I放射性粒子植入治疗不可切除胰腺癌的研究进展[J]. 临床肝胆病杂志,2016,32(5):972-976. doi: 10.3969/j.issn.1001-5256.2016.05.040
[11]	杜小丽,刘兆玉,贺倩,等. ¹²⁵I粒子对胆管细胞癌HCCC-9810 细胞凋亡及Livin 基因表达的影响[J]. 安徽医科大学学报,2020,55(11):1714-1717.
[12]	Zhu H D,Guo J H,Huang M,et al. Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction:A multicenter trial[J]. J Hepatol,2018,68(5):970-977. doi: 10.1016/j.jhep.2017.12.028
[13]	刘一铭,许凯豪,焦德超,等. ¹²⁵I放射性粒子双链胆道引流管近距离放疗联合经动脉灌注化疗序贯治疗局部进展期胰腺癌[J]. 中国介入影像与治疗学,2022,19(2):80-84.
[14]	胡章明,李坤峰,姚宜斌,等. 胆道支架联合¹²⁵I粒子条对恶性梗阻性黄疸的治疗效果[J]. 介入放射学杂志,2020,29(1):59-62. doi: 10.3969/j.issn.1008-794X.2020.01.012
[15]	徐红豆,周卫忠,刘圣,等. 经皮胆道支架联合¹²⁵I 粒子条腔内植入治疗恶性梗阻性黄疸的疗效分析[J]. 介入放射学杂志,2020,29(1):83-88. doi: 10.3969/j.issn.1008-794X.2020.01.017

Relative Articles(20)

Relative Articles

[1]	Fei SONG, Jiayin CHE, Ming HUANG, Dan XU, Hongyang LI, Dingkun LI, Yingying XIANG. The Role of Radioactive Iodine-125 Particles in EMT and Clinical Treatment of Lung Adenocarcinoma. Journal of Kunming Medical University, 2023, 44(1): 140-143. doi: 10.12259/j.issn.2095-610X.S20230101
[2]	Hong LI. Quantitative Analysis of Real-time Ultrasound Elastography in Elderly Patients with Advanced Malignant Obstructive Jaundice in Assessing the Prognosis of PTCD. Journal of Kunming Medical University, 2023, 44(2): 150-155. doi: 10.12259/j.issn.2095-610X.S20230206
[3]	Hong LI. Quantitative Analysis of Real-time Ultrasound Elastography in Elderly Patients with Advanced Malignant Obstructive Jaundice and the Assessment of Prognostic Value of PTCD. Journal of Kunming Medical University, 2023, 44(1): 122-127. doi: 10.12259/j.issn.2095-610X.S20230123
[4]	Gang LI, Shaohua YANG, Meng SHEN, Nan XIE, Guanbo ZHANG, Jiaxing WANG, Jinsong LI. Expression and Clinical Significance of Eukaryotic Translation Initiation Factors 5A2 and Ki67 in Intrahepatic Cholangiocarcinoma. Journal of Kunming Medical University, 2022, 43(6): 7-12. doi: 10.12259/j.issn.2095-610X.S20220630
[5]	Yao ZOU, Ziyu WANG, Jiao LI, Xingxin LI, Yaqiong SHEN, Jing XU, Yan JIN. Association between LOXL2 and Snail Expression Levels and Overall Survival Rate after Surgery in Patients with Cholangiocarcinoma. Journal of Kunming Medical University, 2022, 43(12): 81-87. doi: 10.12259/j.issn.2095-610X.S20221215
[6]	Liu-zheng LI, Shun LU, Shi-rong ZHANG, Lei-sheng XU, Hai-rong ZHAO, Jia-wei FENG, Xue-chan GAO, Tong WU. Curative Effect of Combined Hemihepatectomy and Perihilar Hepatectomy in Treatment of Hilar Cholangiocarcinoma. Journal of Kunming Medical University, 2021, 42(10): 121-126. doi: 10.12259/j.issn.2095-610X.S20211014
[7]	Shao-hua YANG, Zhou-Jun LIAO, Sheng HU, Mao-lin HONG, Zhi-Mei SONG, Qun WEI, Xiao-wen ZHANG. The Expression and Significance of Eukaryotic Translation Initiation Factor-5A2 in Intrahepatic Cholangiocarcinoma. Journal of Kunming Medical University, 2021, 42(5): 24-28. doi: 10.12259/j.issn.2095-610X.S20210505
[8]	Gang LI, Jin-song LI, Nan XIE, Chun-mang LI, Lei WEI, Fan CAO, Ying-zhen SU. Expression of B7-H4 in Intrahepatic Cholangiocarcinoma and Its Clinical Significance. Journal of Kunming Medical University, 2021, 42(4): 78-83. doi: 10.12259/j.issn.2095-610X.S20210415
[9]	Zhi-qiang LI, Hong-qiang GAO, Jing-feng LI, Jie-qi YU, Dong-dong WANG, Gang CHEN, Guang CHU. Expression of ICAM-1, MMP-9 and NF-κB in Cholangiocarcinoma and Their Relationship with Immunosuppressive Cells in Peripheral Blood. Journal of Kunming Medical University, 2021, 42(11): 93-98. doi: 10.12259/j.issn.2095-610X.S20211117
[10]	Yan-bo SUN, Wei-ming LI, Shu-min LI, Yue-ying LIN, Yun-yun CEN, Peng-yuan XU. A Comparative Study of Fecal Bacteria between Patients with Malignant Obstructive Jaundice and Healthy People. Journal of Kunming Medical University, 2021, 42(5): 87-91. doi: 10.12259/j.issn.2095-610X.S20210516
[11]	Hou Feng Qiang , Dong Shan Chao , Lei Xi Feng , Zhang Wei . Effects of Paclitaxel on Gene and Protein Expression of wnt/β-catenin Signaling Pathway in Cholangiocarcinoma Cell Line QBC939. Journal of Kunming Medical University, 2017, 38(04): 10-13.
[12]	Kang Qiang . Expression of E-cadherin and Vimentin and Clinic Significance in Intrahepatic Cholangiocarcinoma. Journal of Kunming Medical University,
[13]	Li Zheng . The Diagnosis of Intrahepatic Bile Duct Stones with Early Intrahepatic Cholangiocarcinoma by Combining CA199, CEA, CA50 and ALP and Magnetic Resonance Imaging. Journal of Kunming Medical University,
[14]	Wang Shi Ping . . Journal of Kunming Medical University,
[15]	Wang Tian Yang . . Journal of Kunming Medical University,
[16]	Peng Bo . . Journal of Kunming Medical University,
[17]	Yang Shi Kun . . Journal of Kunming Medical University,
[18]	Yang Jie . Clinical Application of I125-seed Implantation Combined with Gimeracil and Oteracil Capsules Adjuvant Chemotherapy in the Treatment of Head and Neck Cancer. Journal of Kunming Medical University,
[19]	Ji Ye . . Journal of Kunming Medical University,
[20]	. The Preliminary Study of FSHR and SCF Expression in Testicular Tissues of Patients with Obstructive and Non-obstructive Azoospermia. Journal of Kunming Medical University,